The Imaging Dilemma of Solid Serous Cystadenomas, PNETs, and Vascular Pancreatic Metastases: Challenges and Diagnostic Strategies Video

Solid cirrhosis adenomas, a rare subtype of pancreatic lesions, present significant diagnostic challenges, particularly when differentiating them from neuroendocrine tumors and vascular metastases. These benign lesions, typically found in women aged 60 to 80, are often misidentified due to their hypervascular characteristics, which can resemble more serious conditions. Recent advancements in diagnostic techniques, including the use of the VHL marker, have improved the accuracy of identifying these adenomas, which account for less than 5% of all serous cystadenomas.

The discussion highlights the importance of recognizing solid cirrhosis adenomas as non-malignant entities that do not usually require surgical intervention unless they cause symptoms due to size. In contrast, neuroendocrine tumors, which can be functioning or non-functioning, often necessitate resection, especially when they exceed 2 cm in size due to their potential for malignancy. The podcast emphasizes the need for careful imaging and biochemical testing to differentiate between these conditions, as misdiagnosis can lead to unnecessary surgeries.

Additionally, the episode touches on the prevalence of metastatic lesions in the pancreas, particularly from renal cell carcinoma, which can mimic the appearance of neuroendocrine tumors. The speaker underscores the rarity of pancreatic metastases and the importance of thorough follow-up in patients with a history of renal cancer. Overall, the conversation reflects ongoing efforts to enhance diagnostic accuracy in pancreatic lesions, with a focus on distinguishing solid cirrhosis adenomas from more concerning pathologies.

10/26/2026 | The Imaging Dilemma of Solid Serous Cystadenomas, PNETs, and Vascular Pancreatic Metastases: Challenges and Diagnostic Strategies